Identification of pathologically insignificant prostate cancer is not accurate in unscreened men

被引：0
|
作者：
G L Shaw
B C Thomas
S N Dawson
G Srivastava
S L Vowler
V J Gnanapragasam
N C Shah
A Y Warren
D E Neal
机构：
[1] Cancer Research UK Cambridge Institute,
[2] University of Cambridge,undefined
[3] Li Ka Shing Centre,undefined
[4] Robinson Way,undefined
[5] Cambridge University Hospitals NHS Foundation Trust,undefined
[6] Hills Road,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
active surveillance; prostate cancer; PSA screening; risk stratification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2405 / 2411
页数：6
相关论文
共 50 条
  • [1] Identification of pathologically insignificant prostate cancer is not accurate in unscreened men
    Shaw, G. L.
    Thomas, B. C.
    Dawson, S. N.
    Srivastava, G.
    Vowler, S. L.
    Gnanapragasam, V. J.
    Shah, N. C.
    Warren, A. Y.
    Neal, D. E.
    BRITISH JOURNAL OF CANCER, 2014, 110 (10) : 2405 - 2411
  • [2] Tools to predict insignificant prostate cancer are inaccurate in unscreened men
    Sarah Payton
    Nature Reviews Urology, 2014, 11 (5) : 246 - 246
  • [3] Validation of active surveillance criteria for pathologically insignificant prostate cancer in Asian men
    Yamada, Yasutaka
    Sakamoto, Shinichi
    Sazuka, Tomokazu
    Goto, Yusuke
    Kawamura, Koji
    Imamoto, Takashi
    Nihei, Naoki
    Suzuki, Hiroyoshi
    Akakura, Koichiro
    Ichikawa, Tomohiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (01) : 49 - 54
  • [4] Editorial Comment to Validation of active surveillance criteria for pathologically insignificant prostate cancer in Asian men
    Abreu, Andre Luis de Castro
    Ukimura, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (01) : 55 - 55
  • [5] Low-volume prostate cancer is not necessarely pathologically and clinically insignificant
    El-Gabry, E
    Zhou, M
    Skacel, M
    Myles, J
    Levin, HS
    Reuther, AM
    Klein, E
    Magi-Galluzzi, C
    MODERN PATHOLOGY, 2005, 18 : 138A - 138A
  • [6] Low-volume prostate cancer is not necessarely pathologically and clinically insignificant
    Zhou, M
    El-Gabry, E
    Skacel, M
    Myles, J
    Levin, HS
    Reuther, AM
    Klein, EA
    Magi-Galluzzi, C
    JOURNAL OF UROLOGY, 2005, 173 (04): : 454 - 454
  • [7] Low-volume prostate cancer is not necessarely pathologically and clinically insignificant
    El-Gabry, E
    Zhou, M
    Skacel, M
    Myles, J
    Levin, HS
    Reuther, AM
    Klein, E
    Magi-Galluzzi, C
    LABORATORY INVESTIGATION, 2005, 85 : 138A - 138A
  • [8] Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer
    Capitanio, Umberto
    Ahyai, Sasha
    Graefen, Markus
    Jeldres, Claudio
    Shariat, Shahrokh F.
    Erbersdobler, Andreas
    Schlomm, Thorsten
    Haese, Alexander
    Steuber, Thomas
    Heinzer, Hans
    Perrotte, Paul
    Peloquin, Frangois
    Pharand, Daniel
    Arjane, Philippe
    Huland, Hartwig
    Karakiewicz, Pierre I.
    UROLOGY, 2008, 72 (06) : 1208 - 1211
  • [9] PROSTATE CANCER ANTIGEN 3 (PCA3) IS AN INDEPENDENT AND SIGNIFICANT PREDICTOR FOR PATHOLOGICALLY INSIGNIFICANT PROSTATE CANCER (PCA) IN MEN UNDERGOING RADICAL PROSTATECTOMY
    Ward, J. F.
    Chun, F.
    Graefen, M.
    Huland, H.
    Koellermann, J.
    Sauter, G.
    Babaian, R. J.
    Haese, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 293 - 293
  • [10] Prostatectomy Findings in Men with "Insignificant" Prostate Cancer on Biopsy
    Prabhu, S. V.
    Rangarajan, S. S.
    Gersbach, E.
    Catalona, W. J.
    Yang, X. J.
    MODERN PATHOLOGY, 2014, 27 : 254A - 254A
12345